Skip to content
Homepage
Author:
TransCelerate BioPharma/ Zero To Five, LLC
Posted Date:
June 9, 2026
TransCelerate Receives DIA Global Inspire Award and Showcases Collaborative Innovation at DIA 2026
TransCelerate BioPharma/ Zero To Five, LLC
June 9, 2026
TransCelerate Research Examines the Role of Digital Health Technologies in Patient Safety, Published in DIA’s Therapeutic Innovation & Regulatory Science
TransCelerate BioPharma/ Zero To Five, LLC
May 14, 2026
TransCelerate and FDA Advance Collaboration on Streamlined Safety Data Collection to Accelerate Inclusion of Pragmatic Elements in Clinical Trials
TransCelerate BioPharma/ Zero To Five, LLC
May 5, 2026
TransCelerate to Advance Industry Dialogue on Patient-Centered Innovation, AI and Real-World Evidence at PHUSE US Connect 2026
TransCelerate BioPharma/ Zero To Five, LLC
March 12, 2026
TransCelerate BioPharma Releases 2025 Annual Report Highlighting The Power of Forward in Clinical R&D
TransCelerate BioPharma/ Zero To Five, LLC
February 19, 2026
TransCelerate BioPharma Showcases Approaches to Advancing Clinical Trial Efficiency and Patient-Centered Design at SCOPE US 2026
TransCelerate BioPharma/ Zero To Five, LLC
February 4, 2026
